LONDON/ROME (Reuters) – Scientists in Britain began clinical trials of a potential COVID-19 vaccine on Thursday as other vaccine developers across Europe also stepped up work on experimental shots against the disease caused by the new coronavirus.
FILE PHOTO: Small bottles labbeled with a “Vaccine COVID-19” sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic/Illustration/File Photo
A team at Britain’s Oxford University dosed the first volunteers in a trial of their vaccine – called “ChAdOx1 nCoV-19” – while Italy’s ReiThera, Germany’s Leukocare and Belgium’s Univercells said they were working together on another potential shot and aimed to start trials in a few months.
Britain’s GSK and France’s Sanofi last week announced a similar agreement to develop a COVID-19 vaccine, with trials starting in the second half of the year.
As many as 100 potential COVID-19 candidate vaccines are now under development by biotech…
Source news reuters.com, click here to read the full news.